Common Complications in the Critically Ill Patient

Surgical Clinics of North America

Volumn 92, Issue 6, 2012, Pages 1519-1557

  To, Kathleen B ^a   Napolitano, Lena M ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Central line associated bloodstream infection; Surgical site infection; Urinary tract infection; Venous thromboembolism; Ventilator associated pneumonia

Indexed keywords

CATHETER INFECTION; CRITICALLY ILL PATIENT; DEEP VEIN THROMBOSIS; DISEASE SEVERITY; HOSPITAL INFECTION; HUMAN; INDWELLING CATHETER; INTENSIVE CARE UNIT; LUNG EMBOLISM; PRIORITY JOURNAL; REVIEW; SURGICAL INFECTION; TREATMENT OUTCOME; URINARY TRACT INFECTION; VENOUS THROMBOEMBOLISM; VENTILATOR ASSOCIATED PNEUMONIA;

CATHETER-RELATED INFECTIONS; CRITICAL ILLNESS; CROSS INFECTION; FEMALE; HUMANS; INTENSIVE CARE; MALE; PNEUMONIA, VENTILATOR-ASSOCIATED; RISK FACTORS; SURGICAL WOUND INFECTION; VENOUS THROMBOEMBOLISM;

EID: 84869106751     PISSN: 00396109     EISSN: 15583171     Source Type: Journal    
DOI: 10.1016/j.suc.2012.08.018     Document Type: Review

References (117)

1. Klevens R.M., Edwards J.R., Richards C.L., et al. Estimating health care-associated infections and deaths in U.S. hospitals, 2002. Public Health Rep 2007, 122(2):160-166.
2. Darouiche R.O., Raad I.I., Heard S.O., et al. A comparison of two antimicrobial-impregnated central venous catheters. Catheter Study Group. N Engl J Med 1999, 340(1):1-8.
3. Safdar N., Maki D.G. Risk of catheter-related bloodstream infection with peripherally inserted central venous catheters used in hospitalized patients. Chest 2005, 128(2):489-495.
4. Liem T.K., Yanit K.E., Moseley S.E., et al. Peripherally inserted central catheter usage patterns and associated symptomatic upper extremity venous thrombosis. J Vasc Surg 2012, 55(3):761-767.
5. Horan T.C., Andrus M., Dudeck M.A. CDC/NHSN surveillance definition of healthcare-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008, 36:309-332.
6. Mermel L.A., Allon M., Bouza E., et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009, 49:1-45.
7. Rosenthal M.B. Nonpayment for performance? Medicare's new reimbursement rule. N Engl J Med 2007, 357(6):1573-1575.
8. Pronovost P., Needham D., Berenholtz S., et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med 2006, 355:2725-2732.
9. Clancy C.M. Progress on a national patient safety imperative to eliminate CLABSI. Am J Med Qual 2012, 27(2):170-171.
10. Vital signs: central line-associated blood stream infections-United States, 2001, 2008, 2009. MMWR Morb Mortal Wkly Rep 2011, 60:243-248. Centers for Disease Control and Prevention.
11. O'Grady N.P., Alexander M., Burns L.A., et al. Guidelines for the prevention of intravascular catheter-related infections. Am J Infect Control 2011, 39(4 Suppl 1):S1-34. Healthcare Infection Control Practices Advisory Committee.
12. O'Grady N.P., Alexander M., Burns L.A., et al. Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis 2011, 52(9):e162-e193. Healthcare Infection Control Practices Advisory Committee (HICPAC).
13. Casey A.L., Mermel L.A., Nightingale P., et al. Antimicrobial central venous catheters in adults: a systematic review and meta-analysis. Lancet Infect Dis 2008, 8:763-776.
14. Timsit J.F., Schwebel C., Bouadma L., et al. Chlorhexidine-impregnated sponges and less frequent dressing changes for prevention of catheter-related infections in critically ill adults: a randomized controlled trial. JAMA 2009, 301(12):1231-1241. Dressing Study Group.
15. Restrepo M.I., Anzueto A., Arroliga A.C., et al. Economic burden of ventilator-associated pneumonia based on total resource utilization. Infect Control Hosp Epidemiol 2010, 31(5):509-515.
16. Magnotti L.J., Croce M.A., Fabian T.C. Is ventilator-associated pneumonia in trauma patients an epiphenomenon or a cause of death?. Surg Infect (Larchmt) 2004, 5(3):237-242.
17. O'Keefe G.E., Caldwell E., Cuschieri J., et al. Ventilator-associated pneumonia: bacteremia and death after traumatic injury. J Trauma Acute Care Surg 2012, 72(3):713-719.
18. Napolitano L.M. Perspectives in surgical infections: what does the future hold?. Surg Infect (Larchmt) 2010, 11(2):111-123. [review].
19. Arozullah A.M., Khuri S.F., Henderson W.G., et al. Development and validation of a multifactorial risk index for predicting postoperative pneumonia after major noncardiac surgery. Ann Intern Med 2001, 135(10):847-857.
20. Napolitano L.M. Use of severity scoring and stratification factors in clinical trials of hospital-acquired and ventilator-associated pneumonia. Clin Infect Dis 2010, 51(Suppl 1):S67-S80.
21. Ozhathil D.K., Li Y., Smith J.K., et al. Colectomy performance improvement within NSQIP 2005-2008. J Surg Res 2011, 171(1):e9-e13.
22. Hubmayr R.D., Burchardi H., Elliot M., et al. Statement of the 4th International Consensus Conference in Critical Care on ICU-Acquired Pneumonia-Chicago, Illinois, May 2002. Intensive Care Med 2002, 28:1521.
23. Johanson W.G., Pierce A.K., Sanford J.P. Changing pharyngeal bacterial flora of hospitalized patients: emergence of gram-negative bacilli. N Engl J Med 1969, 281:1137.
24. de Jonge E., Schultz M.J., Spanjaard L., et al. Effects of selective decontamination of digestive tract on mortality and acquisition of resistant bacteria in intensive care: a randomized controlled trial. Ann Intern Med 2003, 362:1011.
25. Adair C.G., Gorman S.P., Feron B.M., et al. Implications of endotracheal tube biofilm for ventilator-associated pneumonia. Intensive Care Med 1999, 25:1072.
26. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005, 171(4):388-416. American Thoracic Society, Infectious Diseases Society of AmericaInfectious Diseases Society of America.
27. Available at: Accessed April 20, 2012. http://www.cdc.gov/nhsn/PDFs/vae/CDC_VAE_CommunicationsSummary-for-compliance_20120313.pdf.
28. Meduri G.U. Diagnosis and differential diagnosis of ventilator-associated pneumonia. Clin Chest Med 1995, 16:61.
29. Fàbregas N., Ewig S., Torres A., et al. Clinical diagnosis of ventilator associated pneumonia revisited: comparative validation using immediate post-mortem lung biopsies. Thorax 1999, 54:867.
30. Wunderink R.G., Woldenberg L.S., Zeiss J., et al. The radiologic diagnosis of autopsy-proven ventilator-associated pneumonia. Chest 1992, 101:458.
31. Kollef M.H., Bock K.R., Richards R.D., et al. The safety and diagnostic accuracy of minibronchoalveolar lavage in patients with suspected ventilator-associated pneumonia. Ann Intern Med 1995, 122:743.
32. Shorr A.F., Sherner J.H., Jackson W.L., et al. Invasive approaches to the diagnosis of ventilator-associated pneumonia: a meta-analysis. Crit Care Med 2005, 33:46.
33. Klompas M. Does this patient have ventilator-associated pneumonia?. JAMA 2007, 297(14):1583-1593.
34. Luyt C.E., Combes A., Reynaud C., et al. Usefulness of procalcitonin for the diagnosis of ventilator-associated pneumonia. Intensive Care Med 2008, 34(8):1434-1440.
35. Ramirez P., Garcia M.A., Ferrer M., et al. Sequential measurements of procalcitonin levels in diagnosing ventilator-associated pneumonia. Eur Respir J 2008, 31(2):356-362.
36. Linssen C.F., Bekers O., Drent M., et al. C-reactive protein and procalcitonin concentrations in BAL fluid as a predictor of ventilator-associated pneumonia. Ann Clin Biochem 2008, 45:293-298.
37. Gibot S., Cravoisy A., Levy B., et al. Soluble triggering receptor expressed on myeloid cells and the diagnosis of pneumonia. N Engl J Med 2004, 350(5):451-458.
38. Determann R.M., Millo J.L., Gibot S., et al. Serial changes in soluble triggering receptor expressed on myeloid cells in the lung during development of ventilator-associated-pneumonia. Intensive Care Med 2005, 31(11):1495-1500.
39. Anand N.J., Zuick S., Klesney-Tait J., et al. Diagnostic implications of soluble triggering receptor expressed on myeloid cells-1 in BAL fluid of patients with pulmonary infiltrates in the ICU. Chest 2009, 135(3):641-647.
40. Oudhuis G.J., Beuving J., Bergmans D., et al. Soluble triggering receptor expressed on myeloid cells-1 in bronchoalveolar lavage fluid is not predictive for ventilator-associated pneumonia. Intensive Care Med 2009, 35(7):1265-1270.
41. Meduri G.U., Johanson W.G. International Consensus Conference: clinical investigation of ventilator-associated pneumonia. Chest 1992, 102:551S.
42. CDC. National Nosocomial Infections Surveillance (NNIS) system report, data summary from January 1990-May 1999, issued June 1999. Am J Infect Control 1999, 27:520-532.
43. Fridkin S., Weibel S.F., Weinstein R.A. Magnitude and prevention of nosocomial infections in the intensive care unit. Infect Dis Clin North Am 1997, 11:479-496.
44. Hidron A.I., Edwards J.R., Patel J., et al. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention 2006-2007. Infect Control Hosp Epidemiol 2008, 29:996-1011. National Healthcare Safety Network Team, Participating National Healthcare Safety Network FacilitiesParticipating National Healthcare Safety Network Facilities.
45. Hanberger H., Walther S., Leone M., et al. Increased mortality associated with methicillin-resistant Staphylococcus aureus (MRSA) infection in the intensive care unit: results from the EPIC II study. Int J Antimicrob Agents 2011, 38(4):331-335. EPIC II Group of Investigators.
46. Park D.R. The microbiology of ventilator-associated pneumonia. Respir Care 2005, 50(6):742-763. [discussion: 763-5].
47. Napolitano L.M., Brunsvold M.E., Reddy R.C., et al. Community-acquired MRSA pneumonia and ARDS: 1-year followup. Chest 2009, 136(5):1407-1412.
48. Hidron A.I., Low C.E., Honig E.G., et al. Emergence of community-acquired MRSA strain USA300 as a cause of necrotizing community-onset pneumonia. Lancet Infect Dis 2009, 9:384-392.
49. Kallen A.J., Brunkard J., Moore Z., et al. Staphylococcus aureus community-acquired pneumonia during the 2006-2007 influenza season. Ann Emerg Med 2009, 53(3):358-365.
50. Labandeira-Rey M., Couzon F., Boisset S., et al. Staphylococcus aureus Panton-Valentine leukocidin causes necrotizing pneumonia. Science 2007, 315:1130-1133.
51. Wenzel R.P., Bearman G., Edmond M.B. Community-acquired methicillin-resistant Staphylococcus aureus (MRSA): new issues for infection control. Int J Antimicrob Agents 2007, 30:210-212.
52. Rello J., Ollendorf D.A., Oster G., et al. Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest 2002, 122:2115.
53. Iregui M., Ward S., Sherman G., et al. Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. Chest 2002, 122:262.
54. Habarth S., Garbino J., Pugin, et al. Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis. Am J Med 2003, 115(7):529-535.
55. Luna C.M., Vujacich P., Niederman M.S., et al. Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia. Chest 1997, 111:676.
56. Kollef M.H., Sherman G., Ward S., et al. Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 1999, 115(2):462-474.
57. Teixeira P.J., Seligman R., Hertz F.T., et al. Inadequate treatment of ventilator-associated pneumonia: risk factors and impact on outcomes. J Hosp Infect 2007, 65(4):361-367.
58. Chan J.D., Dellit T.H., Choudhuri J.A., et al. Active surveillance cultures of methicillin-resistant Staphylococcus aureus as a tool to predict methicillin-resistant S. aureus ventilator-associated pneumonia. Crit Care Med 2012, 40(5):1437-1442.
59. Chastre J., Wolff M., Fagon J.Y., et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. JAMA 2003, 290:2588.
60. Demoule A., Girou E., Richard J.C., et al. Increased use of noninvasive ventilation in French intensive care units. Intensive Care Med 2006, 32(11):1747-1755.
61. Muscedere J., Dodek P., Keenan S., et al. Comprehensive evidence-based clinical practice guidelines for ventilator-associated pneumonia: prevention. J Crit Care 2008, 23(1):126-137. VAP Guidelines Committee and the Canadian Critical Care Trials Group.
62. Wip C., Napolitano L. Bundles to prevent ventilator-associated pneumonia: how valuable are they?. Curr Opin Infect Dis 2009, 22(2):159-166.
63. Drakulovic M.B., Torres A., Bauer T.T., et al. Supine body position as a risk factor for nosocomial pneumonia in mechanically ventilated patients: a randomised trial. Ann Intern Med 1999, 354:1851.
64. van Nieuwenhoven C.A., Vandenbroucke-Grauls C., van Tiel F.H., et al. Feasibility and effects of the semirecumbent position to prevent ventilator-associated pneumonia: a randomized study. Crit Care Med 2006, 34(2):396-402.
65. Alexiou V.G., Ierodiakonou V., Dimopoulos G., et al. Impact of patient position on the incidence of ventilator-associated pneumonia: a meta-analysis of randomized controlled trials. J Crit Care 2009, 24(4):515-522.
66. Bouza E., Perez M.J., Munoz P., et al. Continuous aspiration of subglottic secretions in the prevention of ventilator-associated pneumonia in the postoperative period of major heart surgery. Chest 2008, 134(5):938-946.
67. Dezfulian C., Shojania K., Collard H.R., et al. Subglottic secretion drainage for preventing ventilator-associated pneumonia: a meta-analysis. Am J Med 2005, 118(1):11-18.
68. Diaz E., Rodríguez A.H., Rello J., et al. Ventilator-associated pneumonia: issues related to the artificial airway. Respir Care 2005, 50(7):900-906. [discussion: 906-9].
69. DeRiso A.J., Ladowski J.S., Dillon T.A., et al. Chlorhexidine gluconate 0.12% oral rinse reduces the incidence of total nosocomial respiratory infection and nonprophylactic systemic antibiotic use in patients undergoing heart surgery. Chest 1996, 109:1556.
70. Koeman M., van der Ven A.J., Hak E., et al. Oral decontamination with chlorhexidine reduces the incidence of ventilator-associated pneumonia. Am J Respir Crit Care Med 2006, 173(12):1348-1355.
71. Chlebicki M.P., Safdar N. Topical chlorhexidine for prevention of ventilator-associated pneumonia: a meta-analysis. Crit Care Med 2007, 35(2):595-602.
72. Genuit T., Bochicchio G., Napolitano L.M., et al. Prophylactic chlorhexidine oral rinse decreases ventilator-associated pneumonia in surgical ICU patients. Surg Infect (Larchmt) 2001, 2(1):5-18.
73. Lorente L., Lecuona M., Jiménez A., et al. Ventilator-associated pneumonia with or without toothbrushing: a randomized controlled trial. Eur J Clin Microbiol Infect Dis 2012, 31(10):2621-2629.
74. Pobo A., Lisboa T., Rodriguez A., et al. A randomized trial of dental brushing for preventing ventilator-associated pneumonia. Chest 2009, 136(2):433-439. RASPALL Study Investigators.
75. Kollef M.H., Afessa B., Anzueto A., et al. Silver-coated endotracheal tubes and incidence of ventilator-associated pneumonia: the NASCENT randomized trial. JAMA 2008, 300(7):805-813. NASCENT Investigation Group.
76. Garrard C.S., A'Court C.D. The diagnosis of pneumonia in the critically ill. Chest 1995, 108(Suppl 2):17S-25S.
77. Girard T.D., Kress J.P., Fuchs B.D., et al. Efficacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (Awakening and Breathing Controlled trial): a randomised controlled trial. Lancet 2008, 371(9607):126-134.
78. de Smet A.M., Kluytmans J.A., Cooper B.S., et al. Decontamination of the digestive tract and oropharynx in ICU patients. N Engl J Med 2009, 360:20.
79. D'Amico R., Pifferi S., Leonetti C., et al. Effectiveness of antibiotic prophylaxis in critically ill adult patients: systematic review of randomised controlled trials. BMJ 1998, 316:1275.
80. Silvestri L., van Saene H.K., Casarin A., et al. Impact of selective decontamination of the digestive tract on carriage and infection due to Gram-negative and Gram-positive bacteria: a systematic review of randomised controlled trials. Anaesth Intensive Care 2008, 36:324.
81. Wunderink R.G. Welkommen to our world. Emergence of antibiotic resistance with selective decontamination of the digestive tract. Am J Respir Crit Care Med 2010, 181:426.
82. Rumbak M.J., Newton M., Truncale T., et al. A prospective, randomized, study comparing early percutaneous dilational tracheotomy to prolonged translaryngeal intubation (delayed tracheotomy) in critically ill medical patients. Crit Care Med 2004, 32(8):1689-1694.
83. Terragni P.P., Antonelli M., Fumagalli R., et al. Early vs late tracheotomy for prevention of pneumonia in mechanically ventilated adult ICU patients: a randomized controlled trial. JAMA 2010, 303(15):1483-1489.
84. Cuthbertson BH. The TracMan trial presented at Critical Care Canada Forum on October 28, 2009, Toronto, Ontario, Canada. Available at: Accessed April 20, 2012. http://www.criticalcarecanada.com/pdf/CCCF%202009%20Final%20Programme%20Wednesday.pdf.
85. Barsanti M.C., Woeltje K.F. Infection prevention in the intensive care unit. Infect Dis Clin North Am 2009, 23(3):703-725.
86. Oman K.S., Makic M.B., Fink R., et al. Nurse-directed interventions to reduce catheter-associated urinary tract infections. Am J Infect Control 2012, 40(6):548-553.
87. Gould C.V., Umscheid C.A., Agarwal R.K., et al. Guideline for prevention of catheter-associated urinary tract infections 2009. Infect Control Hosp Epidemiol 2010, 31(4):319-326. Healthcare Infection Control Practices Advisory Committee.
88. Hooton T.M., Bradley S.F., Cardenas D.D., et al. Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. Clin Infect Dis 2010, 50(5):625-663. Infectious Diseases Society of America.
89. Griffiths R., Fernandez R. Strategies for the removal of short-term indwelling urethral catheters in adults. Cochrane Database Syst Rev 2007, (2). CD004011.
90. Available at: Accessed April 20, 2012. http://www.cdc.gov/HAI/pdfs/toolkits/CAUTItoolkit_3_10.pdf.
91. Laupland K.B., Bagshaw S.M., Gregson D.B., et al. Intensive care unit-acquired urinary tract infections in a regional critical care system. Crit Care 2005, 9(2):R60-R65.
92. Available at: Accessed April 20, 2012. http://www.cdc.gov/nhsn/pdfs/pscManual/7pscCAUTIcurrent.pdf.
93. Approved: new infection-related National Patient Safety Goal for 2012: catheter-associated urinary tract infections pose high risk. Jt Comm Perspect 2011, 31(7):6-7. Joint Commission on Accreditation of Healthcare Organizations.
94. Available at: Accessed April 20, 2012. http://www.jointcommission.org/assets/1/18/r3_report_issue_2_9_22_11_final.pdf.
95. Niel-Weise B.S., van den Broek P.J. Urinary catheter policies for short-term bladder drainage in adults. Cochrane Database Syst Rev 2005, (3). CD004203.
96. Moore K.N., Fader M., Getliffe K. Long-term bladder management by intermittent catheterisation in adults and children. Cochrane Database Syst Rev 2007, (4). CD006008.
97. Marra A.R., Sampaio Camargo T.Z., Gonçalves P., et al. Preventing catheter-associated urinary tract infection in the zero-tolerance era. Am J Infect Control 2011, 39(10):817-822.
98. Andreessen L., Wilde M.H., Herendeen P. Preventing catheter-associated urinary tract infections in acute care: the bundle approach. J Nurs Care Qual 2012, 27(3):209-217.
99. Jepson R.G., Craig J.C. Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev 2008, (1). CD001321.
100. Sarkar B., Napolitano L.M. Necrotizing soft tissue infections. Minerva Chir 2010, 65(3):347-362.
101. US Department of Health and Human Services (HHS). HHS action plan to prevent healthcare associated infections: appendices. Appendix G. Available at: Accessed April 5, 2012. http://www.hhs.gov/ophs/initiatives/hai/appendices.html.
102. Culver D.H., Horan T.C., Gaynes R.P., et al. Surgical wound infection rates by wound class, operative procedure, and patient risk index. Am J Med 1991, 91:S152-S157.
103. Mu Y., Edwards J.R., Horan T.C., et al. Improving risk-adjusted measures of surgical site infection for the national healthcare safety network. Infect Control Hosp Epidemiol 2011, 32(10):970-986.
104. Horan T.C., Gaynes R.P., Martone W.J., et al. CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Am J Infect Control 1992, 20:271-274.
105. Napolitano L.M. Severe soft tissue infections. Infect Dis Clin North Am 2009, 23(3):571-591.
106. Napolitano L.M. Early appropriate parenteral antimicrobial treatment of complicated skin and soft tissue infections caused by methicillin-resistant Staphylococcus aureus. Surg Infect (Larchmt) 2008, 9(Suppl 1):s17-s27.
107. May A.K., Stafford R.E., Bulger E.M., et al. Treatment of complicated skin and soft tissue infections. Surg Infect (Larchmt) 2009, 10(5):467-499. Surgical Infection Society.
108. Stevens D.L., Bisno A.L., Chambers H.F., et al. Practice guidelines for the diagnosis and management of skin and soft-tissue infections. Clin Infect Dis 2005, 41(10):1373-1406. Infectious Diseases Society of America.
109. Mitchell J.D., Collen J.F., Petteys S., et al. A simple reminder system improves venous thromboembolism prophylaxis rates and reduces thrombotic events for hospitalized patients1. J Thromb Haemost 2012, 10(2):236-243.
110. Chan C.M., Shorr A.F. Venous thromboembolic disease in the intensive care unit. Semin Respir Crit Care Med 2010, 31(1):39-46.
111. Dalen J.E. Pulmonary embolism: what have we learned since Virchow? Natural history, pathophysiology, and diagnosis. Chest 2002, 122:1440-1456.
112. Gould M.K., Garcia D.A., Wren S.M., et al. Prevention of VTE in nonorthopedic surgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012, 141(Suppl 2):e227S-e277S. American College of Chest Physicians.
113. Bates S.M., Jaeschke R., Stevens S.M., et al. Diagnosis of DVT: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012, 141(Suppl 2):e351S-e418S. American College of Chest Physicians.
114. Guyatt G.H., Akl E.A., Crowther M., et al. Executive summary: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012, 141(Suppl 2):7S-47S. American College of Chest Physicians Antithrombotic Therapy and Prevention of Thrombosis Panel.
115. Holbrook A., Schulman S., Witt D.M., et al. Evidence-based management of anticoagulant therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012, 141(Suppl 2):e152S-e184S. American College of Chest Physicians, [review].
116. Kearon C., Akl E.A., Comerota A.J., et al. Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012, 141(Suppl 2):e419S-e494S. American College of Chest Physicians.
117. Douketis J.D., Spyropoulos A.C., Spencer F.A., et al. Perioperative management of antithrombotic therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012, 141(Suppl 2):e326S-e350S. American College of Chest Physicians.